Viewing Study NCT03646292

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-02-20 @ 10:08 PM
Study NCT ID: NCT03646292
Status: COMPLETED
Last Update Posted: 2025-03-05
First Post: 2018-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Antidiabetic Drugs for Steatotic Liver Disease
Sponsor: Yonsei University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease View
None Type 2 Diabetes View
None Digestive System Disease View
None Liver Diseases View
None Fatty Liver View
None Metabolic Dysfunction-Associated Steatotic Liver Disease View
None Non-Alcoholic Fatty Liver Disease View
None Hypoglycemic Agents View
None Physiological Effects of Drugs View
None Sodium-Glucose Cotransporter 2 Inhibitors View
None Pioglitazone View
None Molecular Mechanisms of Pharmacological Action View
None Empagliflozin View
None Thiazolidinediones View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-alcoholic Fatty Liver Disease View
None Hypoglycemic Agents View
None Physiological Effects of Drugs View
None Sodium-Glucose Cotransporter 2 Inhibitors View
None Pioglitazone View
None Molecular Mechanisms of Pharmacological Action View
None Empagliflozin View
None Metabolic Dysfunction-Associated Steatotic Liver Disease View
None Type 2 Diabetes View
None Digestive System Disease View
None Liver Diseases View
None Fatty Liver View
None Thiazolidinediones View